In December 2025, Castle Biosciences reported Nature Communications data from the largest prospective, multicenter uveal melanoma study showing that combining its DecisionDx-UM test with PRAME gene ...
TripletDGC links disease genes→cell types→diseases via eQTL-scRNA integration, exposing sparse but critical cell drivers and potential comorbidity ...
The Global Gene Expression Market is estimated to be valued at USD 16.56 Bn in 2025 and is expected to reach USD 23.61 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2025 to ...
BostonGene has won four awards in the Research & Development, Product Launches, and Innovation categories in the 2025 ...